featured
Rifaximin May Reduce Risk of Overt Hepatic Encephalopathy After TIPS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial
Ann. Intern. Med 2021 Feb 02;[EPub Ahead of Print], C Bureau, D Thabut, C Jezequel, I Archambeaud, L D'Alteroche, S Dharancy, P Borentain, F Oberti, A Plessier, V De Ledinghen, N Ganne-Carrié, N Carbonell, V Rousseau, A Sommet, JM Péron, JP VinelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.